Key facts
- Notable investors include Zhuhai High-tech Financial Investment, Shenzhen Jiadaogu Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Ruidian Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Ruidian Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ruidian Biotechnology
Manufacturer of scientific instruments intended to advance life science research and animal healthcare. The company offers laboratory equipment for neuroscience, molecular biology, pathology, and veterinary medicine, enabling researchers, universities, hospitals, and clinics to achieve precise experimentation and improved medical outcomes.
- Sector
- Healthcare
- HQ
- Zhuhai, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Ruidian Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ruidian Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ruidian Biotechnology in its N-PORT filings yet. We sweep new filings monthly.